A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

NCT04509193 · clinicaltrials.gov ↗

COMPLETED

Status

116049

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Warfarin

Sponsor

Bayer

Collaborators

[object Object]